[Experience in copaxon treatment in Russia].
Zavalishin
I A
IA
Peresedova
A V
AV
Stoĭda
N I
NI
Adarcheva
L S
LS
Zakharova
M N
MN
Niiazbekova
A S
AS
Askarova
L Sh
LSh
Rebrova
O Iu
OIu
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D000068717:Glatiramer Acetate; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D010455:Peptides; D000068717:Glatiramer Acetate